Professor Peter Hutchinson, Professor of Neurosurgery and Consultant neurosurgeon in Cambridge, has been appointed as president of the Society of British Neurological Surgeons– stressing the honour recognises the work of all his colleagues.
The SBNS was founded in 1926 with the purpose of continued professional development of neurosurgeons, advancing practice and services, and promoting safe and effective care of patients. It has more than 1,000 members.
Professor Hutchinson, best known as Hutch, began his two year term following the Autumn meeting in Birmingham where he thanked members and said he is looking forward to the next two years, and the 100th anniversary of the SBNS in 2026.
During his tenure the SBNS intends to promote the future of neurosurgery- innovation and new technology, expand the global initiative - access to neurosurgery in low and middle countries - and continue to support training and workforce planning. It will also focus on the equality and diversity initiative, the National Neurosurgery Audit Programme, and work with the NHS in terms of commissioning and optimising service delivery.
Professor Hutchinson said:
I feel honoured to be elected to this position, which is recognition of not only my work, but that undertaken by all my colleagues in Cambridge and beyond. It is very much a team effort.
Professor Peter Hutchinson
Professor Hutchinson is already a National Institute for Health and Care Research senior investigator and incoming president of the International Neurotrauma Society (INTS), which in September held a global conference in Cambridge, where Professor Hutchinson spoke about his work as chief medical officer for the British Grand Prix. His appointment to the SBNS presidency coincides with the end of his term as director of clinical research at the Royal College of Surgeons of England.
Professor Hutchinson was also instrumental is setting up the Addenbrooke’s-based Cambridge NIHR HealthTech Research Centre, which brings together NHS partners, business, and patients to develop technologies.
He has led on a plethora of academic and clinical studies and has successfully bid for millions of pounds worth of research funding.